SEC Form D · Amendment · filed March 23, 2017
Oncternal Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Langdon G. Miller · San Diego, CAExecJames B. Breitmeyer, M.D., Ph.D · San Diego, CAExec · DirectorDavid B. Johnson · San Diego, CADirectorCam L. Garner · San Diego, CADirectorScott L. Glenn · San Diego, CADirectorBrian B. Lannutti · San Diego, CAExecDavid F. Hale · San Diego, CADirectorCam B. Gallagher · San Diego, CADirectorLauren G. Otsuki · San Diego, CAExecPaul T. Estrem · New Haven, CTExec · DirectorGene Smestad · Valley City, NDExecThomas A. Roszak · Northfield, ILExecRay Braun · Valley City, NDDirectorMichael A. Moceri · Chicago, ILDirectorGarheng P. Kong · New Haven, CTDirectorErin T. Duffy · New Haven, CTExecStan Johnson · Fargo, NDDirectorCraig Lloyd · Sioux Falls, SDDirectorSteven Kay · San Francisco, CAExecMark Jorgensen · San Francisco, CADirectorDenise Woodard · Jersey City, NJDirectorAllen R. Page · Waxahachie, TXDirectorCalvin E. Webb, Iii · Waxahachie, TXDirectorGayle Troberman · New York, NYDirectorLCM Funds Asset Manager LLC · Milwaukee, WIExecDavid J. Winograd · Milwaukee, WIExec · DirectorMichael Krupka · BOSTON, MAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗